Entries |
Document | Title | Date |
20080253999 | Methods For Differentiating Stem Cells and Uses Thereof in the Treatment of Dental Conditions - The present invention relates to a method for propagating and/or differentiating mammalian cells, the method comprising exposing or co-culturing mammalian cells with one or more of periodontal ligament tissue, periodontal ligament proteins or factors derived from periodontal ligament tissue, to obtain cells having PDL characteristics and fulfilling at least one of the following:
| 10-16-2008 |
20080260694 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof - The invention relates to multipotential expanded mesenchymal precursor progeny (MEMP's), characterised by the early developmental markers STRO-1 | 10-23-2008 |
20090068149 | Use of a Fermented Milk Containing L. Casei for the Manufacture of a Composition for the Prevention or Treatment of a Delayed-Type Hypersensitivity Reaction - The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, | 03-12-2009 |
20090092584 | BIO DEGRADATION OF OXYANIONS SUCH AS PERCHLORATE ON ION EXCHANGE RESINS - Systems and methods for removing perchlorate load off of ion exchange resins are disclosed. The systems and methods rely upon direct contact between the resin and a liquid product formed by the culturing of perchlorate-destroying microorganisms. These methods can be incorporated into methods for removing perchlorate from aqueous streams. A resin product comprising an anion exchange resin with a coating of perchlorate-destroying microorganisms on its surface is also disclosed. | 04-09-2009 |
20090110663 | Method for treatment of bowel disorders - A composition and method for treatment for bowel disorders is described. The composition consists of two parts. First, highly purified, insoluble, chemically unmodified fiber from plants is mixed with an aqueous solution such as water. The second component of the composition is a commercially available probiotic preparation. These commercially probiotic preparations contain large numbers of viable microorganisms of either | 04-30-2009 |
20090148412 | METHODS OF USING A CHOLESTEROL-LOWERING PREPARATION, FOOD SUPPLEMENT AND FOODSTUFF - The present invention relates to cholesterol-lowering preparations, in particular to a bacterial preparation for use as a medicament for lowering of the blood cholesterol level. The present invention provides inter alia a preparation of | 06-11-2009 |
20090155216 | Grafting Material and Agent for Improvement in bone Quality - The present invention has an object to provide a transplant material allowing systemic bone substance improvement to be realized by cell transplant. The present invention teaches to use a transplant material comprising a cell selected from the group consisting of an embryonic stem cell, a mesenchymal stem cell, an osteoblast cell, a preosteoblast, a chondrocyte and a cell having a capability of bone formation through systemic or topical administration for the improvement in bone quality. | 06-18-2009 |
20090180990 | Composition for maintaining healthy kidney function - The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment. | 07-16-2009 |
20090238796 | Preparation for treatment of non-infectious inflammatory intestinal diseases - The invention relates to medicine and can be used for treating non-infectious inflammatory intestinal diseases to enhance efficiency of the non-infectious inflammatory intestinal disease treatment and reduce the length, the inventive preparation contains 5-aminosalicylic acid (5 ASA) or a substance, which decomposes in the organism that 5 ASA is formed, and a liophylically dried microbial mass of live bifido- or lactobacteria or the mixture, said bacteria can be immobilised on a sorbent. The 5 ASA can be powdered or granulated mesalazine or sulphasalazine. To ease the administration of preparation and ensure the dilution of components in defined sectors of the gastrointestinal tract, said components can be grouped in two capsules that jointly represent a single dose, wherein one capsule contains a microbial mass of live bacteria and the other capsule contains mesalazine or sulphasalazine or the capsule containing microbial mass of live bacteria is arranged in the mesalazine or sulphasalazine-containing capsule. | 09-24-2009 |
20090252708 | Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof - Biotherapeutic compositions of a non-pathogenic bacterial strain such as M-17 and its substrains and an anaerobic bacterial antibiotic such as metronidazole, are disclosed. Further disclosed are uses of M-17 or its substrains and an anaerobic bacterial antibiotic for treating disorders caused by anaerobic bacteria, whereby such disorders include, for example, pouchitis, microbial infection, irritable bowel syndrome, inflammatory bowel disease, mucous colitis and diarrhea. | 10-08-2009 |
20090274660 | PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF - Synthetic Stem Cell-like Tissue Healing and Regeneration Medication with Anti-inflammatory, Protein Synthesis, Enzyme Deficiency Activation and Genetic Therapy, and Anti-cancer Agent derived from a series of inventions that include these products of Biomolecular Engineering, Drug Discovery from a Biologic Periodic Table of Applied Biochemistry and Biophysics. Tissue has a self healing effect promoting tissue healing and tissue regeneration. Not only does it maintain good health but also it has been observed that the patient's blood is withdrawn from the patient and applied to the ulcer has healing qualities. Cartilage placed in a wound promotes and accelerates wound healing. The anabolic biochemical and biophysical equivalent of tissue has been found in these embodiments to have the same pharmacologic qualities, when devoid of genetic DNA mismatch and other catabolic factors including the catabolic effects of microorganism overgrowth that lacks pro-biotic qualities. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system. | 11-05-2009 |
20090297481 | ANIMAL FEED SUPPLEMENTS AND USES THEREOF - Described feed supplement compositions containing beneficial viable microorganisms and potentially other beneficial nonviable materials, and methods of use thereof. | 12-03-2009 |
20090324550 | COMPOSITION AND METHOD FOR INHIBITION OF MICROORGANISMS - A composition and method for the inhibition of microorganisms. | 12-31-2009 |
20100021430 | Horse feed and treatment methods - A horse feed mixture and method of treating a horse is disclosed. Feed mixtures disclosed contains more than 15% spelt, vegetable oil and vitamins and have less than 20% by weight fillers and less than 5% by weight sugar. The feed may be used to treat ailments including underweight condition, founder, colic, obesity, ulcers, inflammation, and chronic disease. | 01-28-2010 |
20100040579 | PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION F ILLNESS - The present invention provides probiotic compositions suitable for reducing the incidence and duration of human illness. In particular, the present invention provides methods and compositions suitable for preventing disease in young children. In some particularly preferred embodiments, the present invention finds use in the prevention respiratory disease in children. | 02-18-2010 |
20100047209 | Probiotic composition suitable for animals - The invention provides a probiotic composition to alleviate | 02-25-2010 |
20100068184 | LIVING BODY HEALING ACCELERATOR - The present invention provides a living body healing, having an accelerating activity in the regeneration ability relating to the cure of damages of cells or tissues caused by toxicity of a drug or a wound in a living body, having high safety, and also not causing any side effect even administered for a long period of time. Problems are solved by a living body healing accelerator containing as an active constituent a mixture of a culture solution obtained after cultivation of a microorganism belonging to the | 03-18-2010 |
20100086520 | Compositions, Kits and Uses For Protecting The Skin Against Pathogenic Microorganisms - Described are compositions and kits comprising: (i) microorganisms which are able to stimulate the growth of microorganisms of the resident skin microbial flora and which do not stimulate the growth of microorganisms of the transient pathogenic micro flora and (ii) microorganisms which are able to inhibit the growth of one or more microorganisms of the transient pathogenic skin micro flora and which do not inhibit the growth of microorganisms of the healthy normal resident skin micro flora, in order to protect the skin against pathogenic microorganisms and to treat skin diseases. The present invention also relates to uses of the above mentioned microorganisms and to methods for the production of compositions and kits comprising such microorganisms. | 04-08-2010 |
20100098667 | CULTURE MEDIUM FOR BIFIDOBACTERIUM LONGUM, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD - The present invention provides a triple vital bacteria composition, including: powder of | 04-22-2010 |
20100119486 | ANTIBACTERIAL TREATMENT METHOD - Disclosed is an antibacterial treatment method which has no limitation in the scope of a material to be treated and which enables to reduce the time or cost required for the antibacterial testament. Specifically disclosed is an antibacterial treatment method using an antibacterial agent comprising a powder produced by mixing a microorganism selected from | 05-13-2010 |
20100119487 | CULTURE MEDIUM FOR LACTOBACILLUS ACIDOPHILUS AND STREPTOCOCCUS FAECALIS, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD THEREOF - The present invention provides a triple vital bacteria composition, including: powder of | 05-13-2010 |
20100143306 | USE OF BONE MARROW CELLS FOR LONG TERM CULTURE OF PANCREATIC ISLET CELLS - Bone marrow cells have been demonstrated to be useful in the maintenance of pancreatic islet β cell viability, structure, and/or function in culture for a sustained period. Bone marrow cells were also found to promote β cell growth while reducing inflammatory cytokine release and reduce apoptosis. Moreover, islet cells co-cultured with bone marrow cells were shown to retain insulin response function and to function in an islet cell transplant in a mouse model of diabetes to restore normal insulin secretion. Cord blood cells and isolated peripheral CD34+ blood cells were unable to support β islet cell growth or increase survival. | 06-10-2010 |
20100172873 | STRAINS AND METHODS FOR IMPROVING RUMINANT HEALTH AND/OR PERFORMANCE - Described are strains including | 07-08-2010 |
20100189692 | PROBIOTICS FOR USE IN REDUCING EOSINOPHILIA AND RESPIRATORY ALLERGIES - The present invention provides probiotic compositions suitable for reducing the incidence and duration of nasal eosinophilia and other parameters associated with birch pollen allergy. In some embodiments, the present invention provides methods and/or compositions suitable for reducing nasal and/or respiratory allergy symptoms. | 07-29-2010 |
20100196323 | Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof - The invention relates to a probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive, comprising a mixture of microorganisms, selected from the group | 08-05-2010 |
20100203018 | ZINC-ENRICHED BIOMASS, METHOD FOR THE PREPARATION THEREOF AND PRO-BIOTIC, COSMETIC, DIETARY AND NUTRACEUTIC PRODUCTS COMPRISING THE SAME - The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of | 08-12-2010 |
20100226892 | USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION - Disclosed are methods directed to the cosmetic use of an effective amount of at least one probiotic microorganism especially from the genus | 09-09-2010 |
20100266549 | NOVEL PROBIOTICS FOR PET FOOD APPLICATIONS - The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions intended to improve the health of pets, and to compositions containing the same. | 10-21-2010 |
20100284972 | COMPOSITIONS AND METHODS FOR MAKING ALPHA-(1,2)-BRANCHED ALPHA-(1,6) OLIGODEXTRANS - Compositions for improving the health of a subject comprise alpha-(1,2)-branched alpha-(1,6) oligodextrans, preferably with an average molecular weight between about 10 kDa and 70 kDa, between about 10% and 50% alpha-(1,2)-osidic side chains, and having at least partial indigestibility in the subject. Methods for improving the health of a subject comprise administering the composition to a subject in an amount effective to improve gut health, or to prevent or treat a gastrointestinal disorder, a cholesterol-related disorder, diabetes, or obesity. Methods for making oligodextrans having controlled size and controlled degree of branching comprise providing alpha-(1,6) oligodextrans having an average molecular weight between 0.5 and 100 kDa and introducing at least 10% alpha-(1,2)-osidic side chains onto the alpha-(1,6) oligodextrans. | 11-11-2010 |
20100310518 | Combinations of Flubendiamide and Beneficial Species - The novel combinations of flubendiamide and beneficial species comprising flubendiamide and at least one beneficial species from the orders or suborders of the Araneae, Acari, Dermaptera, Hymenoptera, Coleoptera, Neuroptera, Thysanoptera, Heteroptera, Diptera, Hemiptera, Dermaptera and/or Parasitiformes or at least one bacteria strain or at least one virus strain for the effective control of unwanted pests. | 12-09-2010 |
20100330040 | COMPOSITION WITH SYNBIOTICS - Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed. | 12-30-2010 |
20110020283 | PROBIOTIC, GRAM-POSITIVE BACTERIA FOR THE PROPHYLAXIS, SUPPRESSION, OR ELIMINATION OF ALLERGIC REACTIONS IN HUMANS - A pharmaceutical composition for the prophylaxis, suppression or elimination of allergic reactions in humans, includes probiotic, gram-positive bacteria, such as, for example, | 01-27-2011 |
20110033423 | PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL DISORDERS - The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and methods to relieve symptoms associated with functional bowel disorders, irritable bowel syndrome, functional diarrhea, functional bloating, and other symptoms. | 02-10-2011 |
20110038837 | COMPOSITION FOR IMPROVING INTESTINAL MICROFLORA - The present invention is to provide a composition for improving the intestinal microflora for maintaining a good intestinal microflora. The present invention consists of a composition for improving the intestinal microflora characterized by containing | 02-17-2011 |
20110038838 | Probiotic enhancement of steroid and immune suppressor activity in mammals with chronic diseases - Embodiment include methods for treating cats and dogs with inflammatory bowl disease or inflammatory-like bowl disease or immune mediated hemolytic anemia or atopic dermatitis which are being treated with steroids or immune suppressors which involves the step of administering to the animal a probiotic comprised of | 02-17-2011 |
20110044950 | Infusion of a Mixture of Autologous Bone Marrow-Derived Mononuclear Cells and Autologous or Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Treating Myocardial and/or Cardiovascular Disorders - The present invention is a method for improving cardiac and/or cardiovascular functions in living subjects after the occurrence of a myocardial and/or cardiovascular disorder, involving tissue damage and/or an ischemic event. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow-derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged tissue. Studies have shown that the implant improves blood perfusion in an ischemic tissue and thus contributes to the recovery of cardiac and/or cardiovascular function as assessed by methods of choice, including magnetic resonance imaging (“MRI”), echocardiography, angiography and 99mTc-TF perfusion scintigraphy. | 02-24-2011 |
20110052537 | NITRO-BASED EXPLOSIVE REMEDIATION - Embodiments of techniques for remediating soil contaminated with compounds, particularly nitro-based explosives, are disclosed. Plants capable of taking up the compounds are grown within contaminated soil for a period of time. The plants are exposed to anaerobic microbes in the rumen of a ruminant animal. The ruminal anaerobic microbes degrade the remediable compounds and render them substantially nontoxic to the animal. In some embodiments, the remediable compounds are nitroaromatic compounds, and are degraded by nitroreductases. In other embodiments, microbes are transferred from a consortium enriched in microbes capable of degrading the remediable compounds to a ruminant animal that lacks microbes capable of degrading the remediable compounds. In other embodiments, methods for isolating and identifying ruminal anaerobic microbes capable of degrading remediable compounds are disclosed. | 03-03-2011 |
20110110894 | METHODS, COMPOSITIONS AND SYSTEMS FOR CONTROLLING FOULING OF A MEMBRANE - The present invention provides methods and compositions for improving permeability and flux in a membrane filtration system, especially in water or wastewater treatment processes. | 05-12-2011 |
20110117059 | COMPOSITION OF SOLUBLE INDIGESTIBLE FIBRE AND OF MICROALGAE USED IN THE WELL-BEING FIELD - Described is the use of soluble indigestible fibre for inducing lysis of the cell walls of eukaryotic microalgae in the lumen of the intestine of an omnivorous or carnivorous animal including an intestinal flora and also for synergistically increasing the effect of the indigestible fibre in the induction of the growth of the intestinal flora of an omnivorous or carnivorous animal. The subject matter of the invention is also the composition intended for this use and for a method of improving the health or of food supplementation. | 05-19-2011 |
20110165127 | DAIRY-DERIVED PROBIOTIC COMPOSITIONS AND USES THEREOF - The present application relates to a dairy-derived probiotic composition comprising a propionic bacteria. The composition is particularly useful as a food supplement for normalizing the gastro-intestinal flora. The probiotic bacteria present in the composition contain species of | 07-07-2011 |
20110182860 | BIOCONTROL COMPOSITE MICROBIAL AGENT PSX COMBINATION FOR CONTROLLING SEVERAL SOIL-BORNE DISEASES AND ITS BACTERIOLOGICAL COMPOSITION - A composite biocontrol microbial agent PSX combination controls several soil-borne diseases. The PSX combination was composed of three biocontrol bacteria, which are shaking cultured in the PDA culture solution at 37° C., 180 rpm for 20 to 24 hours, then centrifugated at 4000 g for 10 min, taking the wet bacterium preserved fluid by the ratio of 1:40 to prepare the microbial agent, and then mixing at the ratio of 1:1:1, the total concentration of live bacteria in finished product being of 1×10 | 07-28-2011 |
20110182861 | COSMETIC USE OF MICROORGANISMS FOR THE TREATMENT OF OILY SKIN - The present invention relates to the cosmetic use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof, as an agent for treating and/or preventing oily skin or skin with an oily tendency and the associated skin disorders. | 07-28-2011 |
20110189132 | MICROBIAL PRODUCT CONTAINING MULTIPLE MICROORGANISMS - Methods to reduce or inhibit populations of pathogenic bacteria in animals are disclosed. These methods include providing a number of administrations of probiotic microorganism compositions containing one or more strains or species of probiotic microorganisms. Routes of administration, dosage of administration and pathogenic organisms to be reduced or inhibited are also disclosed. | 08-04-2011 |
20110200561 | Method for Bacteriophage Delivery and Amplification - Disclosed are methods of selecting wide host range bacteriophage capable of growing in a plurality of bacteria including pathogenic and non-pathogenic bacteria and bacteriophage selected by the methods. Also disclosed are methods of treating a subject infected with a pathogenic bacterium using bacteriophage and methods of decontaminating objects using bacteriophage. Also disclosed are methods of producing vaccines. In another aspect, methods of determining bacterial viability and methods of improving the sensitivity of a biosensor using wide host range bacteriophages are disclosed. | 08-18-2011 |
20110223136 | NUTRITIONAL SUPPORT TO PREVENT AND/OR MITIGATE BONE MARROW TOXICITY FROM A CANCEROUS TUMOR - The present invention relates to methods and immunonutritional compositions for preventing or mitigating paralysis of the bone marrow, caused by a tumor or neoplasm, between cycles of and after anti-cancer therapy, thereby attaining a better efficacy of the treatment. More particularly, the present invention relates to methods and immunonutritional compositions that can transiently preventing or moderating, bone marrow paralysis or neutropenia of a subject tumor-induced apoptosis or necrosis or other cell damage such that the innate and adaptive immune functions and normal physiology of the bone marrow are preserved, at least in part, which, in turn, lead to (i) a better tolerance and increased efficacy to treatment; (ii) transient augmentation or enhancement of immunocompetence of the immune cell; and (iii) optimization of the effects of and increase of immunocompetence of the immune cell weakened due to paralysis of the bone marrow, caused by a tumor or neoplasm. | 09-15-2011 |
20110223137 | COMPOSITIONS FOR USE IN LOW-BIRTH WEIGHT INFANTS - The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in low birth weight infants. The invention is also concerned with the use of specific probiotics in the manufacture of low-birth weight infant formulations. | 09-15-2011 |
20110268702 | LACTOBACILLUS PARACASEI AND WEIGHT CONTROL - The present invention generally relates to the field of obesity and/or metabolic disorders. In particular the present invention relates to the use of probiotics to treat obesity and/or metabolic disorders. One embodiment of the present invention relates to the use of | 11-03-2011 |
20110280837 | BIFIDOBACTERIUM LONGUM AND HIPPOCAMPAL BDNF EXPRESSION - The present invention relates in general to edible compositions comprising probiotics. One embodiment of the present invention relates to an edible composition comprising | 11-17-2011 |
20110280838 | TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS - Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells and optionally a hydrogel. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided. | 11-17-2011 |
20110280839 | Entomopathogenic Fungi and Uses Thereof - The present invention provides a strain of entomopathogenic | 11-17-2011 |
20110293568 | LACTOBACILLUS HELVETICUS CNCM I-4095 AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of | 12-01-2011 |
20110293569 | LACTOBACILLUS RHAMNOSUS CNCM I-4096 AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of | 12-01-2011 |
20110300108 | Herbal Compositions for the Control of Hematophagous Parasites - There is described an herbal hematophagous parasite control composition which comprises | 12-08-2011 |
20110305671 | Cell Compositions and Methods for Hair Follicle Generation - The application describes a method of generating a hair follicle, comprising administering a composition comprising epidermal matrix cells, dermal papilla cells, dermal sheath cells and outer root sheath cells to the scalp of a mammal. The composition may optionally be administered with a hair growth agent and/or a carrier. The application also describes a composition comprising epidermal matrix cells, dermal papilla cells, dermal sheath cells and outer root sheath cells and the use of the composition to generate hair follicles. | 12-15-2011 |
20120003185 | BONE-LIKE PROSTHETIC IMPLANTS - A prosthetic implant comprising a biocompatible three-dimensional scaffold and at least two cell types selected from the group consisting of osteoblasts, osteoclasts, and endothelial cells or progenitors thereof. | 01-05-2012 |
20120009154 | Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition - Sunflower lecithin or sunflower lecithin with oleic acid stimulate the growth and lactic acid producing activity of | 01-12-2012 |
20120009155 | Prebiotic Composition for Increasing Probiotic Growth Rate and Activity - Sunflower lecithin or sunflower lecithin with oleic acid stimulate the growth and lactic acid producing activity of | 01-12-2012 |
20120020925 | Therapeutic Use of Specialized Endothelial Progenitor Cells - The invention relates to products, processes, and therapeutic methods for restoring blood flow to tissues at risk of becoming or being ischemic by inducing angiogenesis and/or vasculogenesis in tissues in need thereof by administering endothelial colony forming cells alone or in combination with other cell types and/or agents. In one aspect, the invention is useful for inducing angiogenesis and/or vasculogenesis in patients with ischemic disease including ischemic heart disease, and other ischemic vascular disorders. | 01-26-2012 |
20120027728 | ADJUNCTIVE AGENT FOR LAVAGING THE ALIMENTARY CANAL COMPRISING BUTYRIC ACID BACTERIUM AND/OR LACTIC ACID BACTERIUM - The present invention provides an adjunctive agent and a method for lavaging the alimentary canal, which is able to reduce a dose of oral cleaning agent for lavaging the alimentary canal and is capable of realizing an excellent cleaning effect at the time of use of the oral cleaning agent. The adjunctive agent comprises butyric acid bacterium (for example, | 02-02-2012 |
20120034190 | YEAST STRAINS AND THEIR USES IN THE PRODUCTION OF LIPIDS - The invention is directed to isolated microorganisms, as well as biomasses, cultures, microbial oils, and compositions thereof. The invention also provides methods of producing the microbial oils and methods of using the isolated microorganisms, biomasses, and microbial oils. | 02-09-2012 |
20120039852 | LACTOBACILLUS RHAMNOSUS NCC4007, A PROBIOTIC MIXTURE AND WEIGHT CONTROL - The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the use of | 02-16-2012 |
20120093779 | COMPLEX MICROBIAL PREPARATION FOR TREATING DIABETES AND PREPARATIVE METHOD AND USE THEREOF - A complex microbial preparation comprises (in vol. %): | 04-19-2012 |
20120100108 | COMPOSITIONS AND METHODS OF TREATING NO-OPTION CRITICAL LIMB ISCHEMIA (CLI) - The present invention provides methods for treating critical limb ischemia (CLI), including increasing wound healing, decreasing wound size, increasing survival-free amputation, preventing amputation, preventing or delaying de novo gangrene, increasing survival probability, and preventing or delaying death, in subjects who prevent a vascular occlusion that cannot be resolved by using a standard method of revascularization, i.e. a subject with “no-option” CLI. Methods of the invention include administering to a subject with no-option CLI an isolated cell composition for tissue repair comprising a mixed population of cells of hematopoietic, mesenchymal and endothelial lineage, wherein the viability of said cells is at least 80% and the composition contains: a) about 5-75% viable CD90 | 04-26-2012 |
20120114608 | COMPOSITIONS, METHODS AND KITS FOR ENHANCING IMMUNE RESPONSE TO A RESPIRATORY CONDITION - Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component. Also included are methods of treating a respiratory condition, preferably by enhancing immune response, in a mammal. Kits containing the compositions, and instructions for applying the methods are also included. The method includes orally administering to the mammal a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component. | 05-10-2012 |
20120114609 | BIOLOGICAL MATERIAL SUITABLE FOR THE THERAPY OF OSTEOARTHROSIS, LIGAMENT DAMAGE AND FOR THE TREATMENT OF JOINT DISORDERS - The present invention regards a biological material comprising: a) a liquid carrier comprising a viscous solution containing at least one natural and/or semisynthetic polysaccharide, and having a Dynamic viscosity measured at 20° C. and at shear rate of D=350 s | 05-10-2012 |
20120128632 | IDENTITY MARKERS - Methods for identifying trichogenic dermal cells, including dermal papilla cells and dermal sheath cells, capable of inducing hair follicle formation when injected into skin are provided. It has been discovered that EGF latrophilin and seven transmembrane domain-containing protein 1 (ELTD1). Transmembrane Protein 108 (TMEM1 08), Hyaluronan and proteoglycan link protein 1 (HAPLN1) are biomarkers that can be used to detect, identify, and distinguish trichogenic dermal cells, i.e., that are able to induce hair follicle formation, from other skin cells. Populations of skin cells enriched with trichogenic dermal cells can be produced by selecting for and enriching for dermal cells that express ELTD1, TMEM1 08, HAPLN1, or a combination thereof. | 05-24-2012 |
20120134962 | METHODS AND COMPOSITIONS FOR TISSUE REGENERATION - Disclosed is a method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ, angiopoietin, EGF, IL-Iβ, IL-6, IL-8, TGFα, and TNFα, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof. | 05-31-2012 |
20120134963 | COMPOSITIONS AND METHODS FOR ENHANCING VIRUS EFFICACY - Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided. | 05-31-2012 |
20120156171 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF SENSITIVE OR DRY SKIN - The invention relates to a cosmetic and/or dermatological topical composition, of particular use for the preventional and/or treatment of sensitive and/or dry skin, comprising an effective amount of at least one particularly probiotic microorganism and/or a fraction or metabolite thereof in combination with an effective amount of at least one polyunsaturated fatty acid and/or polyunsaturated fatty acid ester and/or a salt or derivative thereof in a physiologically-acceptable vehicle. | 06-21-2012 |
20120171161 | COMPOSITIONS COMPRISING PLACENTAL STEM CELLS AND PLATELET RICH PLASMA, AND METHODS OF USE THEREOF - Provided herein are compositions comprising placental stem cells and platelet rich plasma. Also provided herein are methods of treating an individual suffering from a disease or condition that would benefit from reduced inflammation, promotion of angiogenesis, and enhanced healing, comprising administering a therapeutically effective amount of a composition comprising placental stem cells and platelet rich plasma, as described herein, to said individual in an amount and for a time sufficient for detectable improvement of said disease or condition. | 07-05-2012 |
20120171162 | FERMENTED FOOD PRODUCTS CONTAINING PROBIOTIC STRAINS, AND METHOD FOR PREPARING SAME - The use of at least one sulphur-containing amino acid, at a total concentration of about 5 to 75 mg/ml, in particular of about 5 to about 50 mg/l, in particular of about 5 to about 30 mg/l, in particular of about 5 to about 20 mg/l, in free form, for implementing a method for preparing a fermented food product fermented by ferments containing bifidobacteria, the food product has acceptable sensory properties, contains more than about 5×10 | 07-05-2012 |
20120183504 | COMPOSITION AND USE OF PROBIOTIC STRAIN GM-263 (ADR-1) IN TREATING RENAL FIBROSIS IN DIABETES - A use of probiotic strain GM-263 (ADR-1) in treating renal fibrosis in diabetes is disclosed. The probiotic strain such as | 07-19-2012 |
20120183505 | ARTIFICIAL DERMIS AND METHOD OF PREPARATION - Artificial dermis ( | 07-19-2012 |
20120207712 | Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin - The present invention relates to compositions comprising probiotic and prebiotic components, mineral salts, lactoferrin, and possibly saccharomycetes, which perform correct, effective colonisation of the probiotic components administered, with enteric consequences which involve maintaining and/or restoring intestinal health and preventing the consequences of common dysbioses of the digestive tract caused by stress, incorrect dietary habits and antibiotic treatments. Said compositions also have a concomitant anti-inflammatory and immunomodulating action. | 08-16-2012 |
20120219526 | NUTRITIONAL COMPOSITIONS COMPRISING LACTOFERRIN AND PROBIOTICS AND KITS OF PARTS THEREOF - The present invention relates to nutritional composition for infants and/or children comprising lactoferrin and probiotics. These compositions have been found to be useful in providing health benefits in infants and/or children. A method of manufacture of these compositions is also part of the invention. These compositions may be in the form of a kit of parts wherein a first composition according to the invention and a second composition according to the invention are each adapted to fulfil the nutritional requirements in two different age groups. | 08-30-2012 |
20120244124 | PROBIOTIC COMPOSITION USEFUL FOR DIETARY AUGMENTATION AND/OR COMBATING DISEASE STATES AND ADVERSE PHYSIOLOGICAL CONDITIONS - A method of combating rheumatoid arthritis, comprising administering to a human subject in need thereof, an effective oral dose of a probiotic composition in an oral dose form including, as the only bacterial species therein, the bacterial species of | 09-27-2012 |
20120244125 | BIFIDOBACTERIUM LONGUM ATCC BAA-999 (BL999) AND WEIGHT CONTROL - The present invention generally relates to the field of weight management. The present invention relates for example to the use of | 09-27-2012 |
20120276054 | Alternative bacterial treatment - Alternative treatments are provided for use in the inhibition, decrease, therapeutic or prophylactic support of a | 11-01-2012 |
20120276055 | COMPOSITION CONTAINING BACTERIUM CAPABLE OF PRODUCING PROPIONIC ACID BACTERIUM, AND USE THEREOF - The invention provides a composition that enhances the proliferation activity of propionic acid bacteria in the rumen of ruminants to allow the propionic acid bacteria to sufficiently exhibit their metabolic function in the rumen for the prevention and treatment of rumen acidosis in ruminants. The invention also provides use of the composition. Viable propionic acid bacteria and a lactic acid bacteria culture are orally administered to a ruminant to dramatically (rapidly) promote the proliferation of the propionic acid bacteria in the ruminant rumen, and to thereby increase the volatile fatty acid concentration in the rumen for the prevention and/or treatment of rumen acidosis in the ruminant. | 11-01-2012 |
20120294833 | STRAINS OF LACTIC ACID BACTERIA FOR PREVENTING NECROTIZING ENTEROCOLITIS - The present invention relates to novel strains of lactic acid bacteria, | 11-22-2012 |
20120308523 | Method for Reducing Gastro-Intestinal Inflammation Using Bifidobacterium Animalis Bacteria or a Fermented Dairy Product Comprising Such Bacteria - The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific | 12-06-2012 |
20120308524 | COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY - The invention provides a composition for use in therapy of lactose intolerance or conditions arising from lactase deficiency, wherein the composition is a non-dairy solid dosage form comprising:
| 12-06-2012 |
20120315249 | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes - The invention provides a method and composition for ameliorating or reducing the symptoms, signs, and markers and for the treatment of irritable bowel syndrome, inflammatory bowel disease or gastritis in a mammal in need thereof, said method comprising administering effective amounts of a pharmaceutically acceptable composition containing at least one probiotic microorganism strain comprising | 12-13-2012 |
20120328572 | BACILLUS BACTERIA FOR USE IN TREATING AND PREVENTING INFECTION IN AQUATIC ANIMALS - Disclosed herein are microbiocidal compositions that include spore-forming strains of | 12-27-2012 |
20120328573 | Composition for Maintaining Healthy Kidney Function - The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment. | 12-27-2012 |
20130017174 | COMPOSITIONS AND METHODS FOR INCREASING HEALTH AND REDUCING PATHOGENIC BACTERIA IN ANIMALS - Probiotic compositions comprising a bacterium that is capable of producing nitric oxide and a substrate of nitric oxide synthase are provided. Also provided are methods of improving the gastrointestinal health of a subject by orally administering a bacterium capable of producing nitric oxide and orally administering a substrate of nitric oxide synthase. Methods of reducing the inflammatory immune response after treatment with a probiotic and methods of reducing horizontal transmission of pathogenic bacteria within groups of animals are also provided. | 01-17-2013 |
20130022575 | SYSTEMS AND METHODS OF REPLACING INTESTINAL FLORA - The invention relates to one or more systems and methods for creating a mixture of cultures used to replace intestinal flora. Specifically, the invention relates to methods and systems of treating diseases including | 01-24-2013 |
20130022576 | COMPOSITIONS AND METHODS FOR REDUCING THE INCIDENCE OF EQUINE DIGESTIVE DISORDERS - The present invention encompasses compositions and methods of reducing the incidence of equine digestive disorders. | 01-24-2013 |
20130022577 | PROBIOTIC COMPOSITIONS USEFUL FOR TREATMENT OF BIPOLAR DISORDER - Compositions and methods for treatment or prophylaxis of a bipolar disorder disease state, in which the compositions include the bacilli (1) | 01-24-2013 |
20130045185 | STRAINS AND METHODS USEFUL FOR MYCOTOXINS - The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are | 02-21-2013 |
20130064795 | IMMUNE MODULATION - The invention provides a layered double hydroxide compound for use in modulating an immune response to an antigen, and an immune modulator composition comprising the layered double hydroxide and an antigen. The compound is of formula (I), (II), or (III) | 03-14-2013 |
20130064796 | METHODS FOR THE PREVENTION AND CONTROL OF PATHOGENIC INFECTIONS IN BEES AND RELATIVE COMPOSITION - The invention relates to a probiotic mixture for the protection of bees' health, and more specifically for the protection from microbial pathologies, such as those caused by | 03-14-2013 |
20130089524 | L. JOHNSONII LA1, B. LONGUM NCC2705 AND IMMUNE DISORDERS - The present invention generally relates to the field of probiotics, and in particular to preventing and/or treating inflammatory and infectious disorders, for example by boosting the endogenous antimicrobial defences. One embodiment of the present invention is a composition comprising a combination of | 04-11-2013 |
20130095073 | SKIN PROPERTIES IMPROVING AGENT FOR ORAL ADMINISTRATION - Disclosed is a skin property-improving agent which exerts excellent effects by oral administration. The skin property-improving agent for oral administration contains, as an active ingredient, a bacterium belonging to the genus | 04-18-2013 |
20130171108 | USE OF ANTI THIRD PARTY CENTRAL MEMORY T CELLS FOR ANTI-LEUKEMIA/LYMPHOMA TREATMENT - A method of treating a disease in a subject in need thereof is disclosed. The method comprising: (a) transplanting a non-syngeneic cell or tissue graft to the subject; and (b) administering to the subject a therapeutically effective amount of an isolated population of cells comprising non-graft versus host (GVHD) inducing anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance-inducing cells and capable of homing to the lymph nodes following transplantation, and further wherein the cells are either: (i) non-syngeneic with both the subject and the graft; or (ii) non-syngeneic with the graft and syngeneic with the subject, thereby treating the subject. | 07-04-2013 |
20130202561 | METHOD OF TREATING DRAINS USING FUNGUS CULTURES - A method of treating drain systems containing organic matter and providing a biopesticide for killing insects is provided. The method comprises introducing into a drain system a bacterial culture, such as | 08-08-2013 |
20130202562 | LIQUID MICROORGANISM CONSORTIA FORMULATION - The present invention is directed to compositions and methods using microorganisms to benefit an environment or recipient subject. The present invention relates to the use of microorganism based compositions and methods to enhance the health of recipient subjects, improve soil conditions, and accelerate biodegradation. The present invention also relates to controlling insect and pest populations. Further, the present invention relates to the replacement of chemical compositions with microorganism based compositions. | 08-08-2013 |
20130224155 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO - Methods and compositions are generally provided for treating metabolic disorders, e.g., obesity. One aspect discloses methods and compositions for obtaining a biological sample from the subject, evaluating the sample for the presence or absence of a genetic indicator, wherein the genetic indicator is selected from a single nucleotide polymorphism and a level of gene expression, and performing a first metabolic procedure if the genetic indicator is present, or performing an alternative second metabolic procedure if the genetic indicator is absent. One aspect discloses methods and compositions for obtaining a sample including deoxyribonucleic acids (DNA) from the subject, evaluating the DNA for an absence or presence of one or more genetic indicators and performing a first metabolic procedure or an alternative second metabolic procedure based on the absence or presence of the genetic indicator(s). Other aspects are also disclosed. | 08-29-2013 |
20130266539 | PROBIOTIC RECOLONISATION THERAPY - The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic Clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of | 10-10-2013 |
20130302283 | hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS - This invention encompasses methods, pharmaceutical compositions, and kits for modulating (e.g. reducing) the production of pro-inflammatory mediators involved in the pathology of a lung disease, disorder, and/or injury in a patient having the lung disease, disorder, and/or injury. The invention also encompasses methods, pharmaceutical compositions, and kits for inhibiting the production of pro-inflammatory mediators involved in the pathology of a lung disease, disorder, and/or injury in a patient having the lung disease, disorder, and/or injury. In one embodiment, the umbilical cord tissue-derived cells are isolated from human umbilical cord tissue substantially free of blood, are capable of self-renewal and expansion in culture, lack the production of CD117 or CD45, and do not express hTERT or telomerase. | 11-14-2013 |
20130330299 | COMPOSITION AND METHOD FOR PREVENTING OR TREATING GOUT OR HYPERURICEMIA - A composition composed of a | 12-12-2013 |
20130336931 | SYNBIOTIC COMPOSITIONS FOR RESTORATION AND RECONSTITUTION OF GUT MICROBIOTA - The present invention relates to synbiotic compositions comprising probiotic bacterial strains and prebiotic substances that, when combined exhibit synergistic behavior. The synergetic compositions will stimulate the indigenous microflora to restore and reconstitute in vivo gut like conditions after antibiotic associated diarrhea (AAD), and/or other gut infections caused by gastrointestinal pathogens, and relapses thereof, as well as the prevention of said disorders. | 12-19-2013 |
20140023620 | PROBIOTIC COMPOSITION - Disclosed herein are probiotic compositions comprising a mixture of at least two probiotic bacteria, including | 01-23-2014 |
20140050702 | Compositions and Methods for Reducing Blood Alcohol Content - Disclosed are compositions and methods for reducing blood alcohol content following alcohol consumption. The inventive compositions and methods rapidly reduce blood alcohol content and alleviate symptoms of intoxication in a subject having an elevated blood alcohol content due to alcohol consumption. | 02-20-2014 |
20140079669 | FORMULATION AND METHOD FOR TREATING PLANTS TO CONTROL OR SUPPRESS A PLANT PATHOGEN - The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are contacted with a formulation including an antagonistic microorganism and a booster composition. The booster composition generally includes about 3 parts Kaolin clay, about 1 part yeast, about 1 part | 03-20-2014 |
20140086875 | COMPOSITION BASED ON BACILLUS SPP. AND CORRELATE GENERA AND THEIR USE IN PEST CONTROL - The objective of the current invention is the control of agricultural infestations based on alternative methods that are less aggressive to the environment and that are harmless to other invertebrates and to man; for instance biological control using bacterial strains belonging to species of the genera | 03-27-2014 |
20140112889 | METHOD FOR REDUCING METHANE PRODUCTION IN A RUMINANT ANIMAL - A method for reducing methane production in a ruminant animal comprising the step of administering to said ruminant animal an effective amount of at least one strain of bacterium of the genus | 04-24-2014 |
20140170115 | Enzyme and Prebiotic Combinations for Enhancing Probiotic Growth and Efficacy - This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and α-galactosidase; and to enhancing growth and/or activity of bifidobacteria using a prebiotic formulation which includes iso-malto oligosaccharides and β-glucanase. Other combinations of fibers and enzymes are described below which also stimulate growth and activity of lactobacilli or bifidobacteria. These combinations of enzymes and prebiotics can be taken separately or added to foods, including desserts. | 06-19-2014 |
20140193367 | Method for reducing uremic toxins by probiotic composition and the manufacturing method thereof - The invention relates to a probiotic composition for reducing uremic toxins and the manufacturing method thereof. The probiotic composition comprises at least one selected from the group consisting of: | 07-10-2014 |
20140193368 | PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF - Synthetic Stem Cell-like Tissue Healing and Regeneration Medication with Anti-inflammatory, Protein Synthesis, Enzyme Deficiency Activation and Genetic Therapy, and Anti-cancer Agent derived from a series of inventions that include these products of Biomolecular Engineering, Drug Discovery from a Biologic Periodic Table of Applied Biochemistry and Biophysics. Tissue has a self healing effect promoting tissue healing and tissue regeneration. Not only does it maintain good health but also it has been observed that the patient's blood is withdrawn from the patient and applied to the ulcer has healing qualities. Cartilage placed in a wound promotes and accelerates wound healing. The anabolic biochemical and biophysical equivalent of tissue has been found in these embodiments to have the same pharmacologic qualities, when devoid of genetic DNA mismatch and other catabolic factors including the catabolic effects of microorganism overgrowth that lacks pro-biotic qualities. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system. | 07-10-2014 |
20140205572 | COMPOSITION AND METHOD FOR INCREASING EFFECTIVENESS OF RADIATION OR CHEMOTHERAPY - This invention is a composition containing prebiotics, | 07-24-2014 |
20140219966 | FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE - Clostridium difficile disease involves a range of clinical presentations ranging from mild to self-limiting diarrhea to life-threatening pseudomembranous colitis and megacolon. Cases of C. difficile are treated differently depending on severity of disease. Mild and moderate cases may be treated with metronidazole while moderate-to-severe and relapsing cases are often treated with vancomycin or fidaxomicin. The presence of C. difficile disease is detected using a biomarker panel that includes C. difficile antigen (GDH), toxins A and B, and fecal lactoferrin. In patients suspected of C. difficile disease, if GDH is detected indicating the presence of C. difficile, and then toxins A and/or B are detected to indicate toxigenic C. difficile and support a diagnosis of C. difficile-associated disease, fecal lactoferrin concentrations are measured to determine severity of the disease by indicating the amount of intestinal inflammation. | 08-07-2014 |
20140234259 | Natural Intra-Vaginal Inserts to Control Imbalanced pH - A vaginal insert controls pH within a human vagina by use of various probiotics which include | 08-21-2014 |
20140234260 | COMPOSITIONS AND METHODS FOR PROBIOTIC RECOLONIZATION THERAPIES - The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic Clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of | 08-21-2014 |
20140242034 | PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL DISORDERS - The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and methods to relieve symptoms associated with functional bowel disorders, irritable bowel syndrome, functional diarrhea, functional bloating, and other symptoms. | 08-28-2014 |
20140255350 | Composition And Methods For Inhibiting Pathogenic Growth - The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of | 09-11-2014 |
20140255351 | Composition Comprising Anaerobically Cultivated Human Intestinal Microbiota - The invention relates to an anaerobic micro-ecological system, a composition comprising anaerobically cultivated human intestinal microbiota for the treatment or prophylaxis of diseases, and wherein the microbiota in the composition have not been exposed to antibiotics used after 1995. The present invention further relates to the use of the composition for the prevention and treatment of disease and a method for preparing the composition. | 09-11-2014 |
20140308248 | Dietary Supplement System for Multifunctional Anti-Aging Management and Method of Use - A dietary supplement system includes a dietary supplement composition for oral administration by an individual in the morning, the composition, including (a) a telomere maintenance complex including: Purslane extract (aerial parts); Turmeric rhizome extract (95% curcuminoids); Quercetin dehydrate, Cayenne pepper fruit; Vanadium (as vanadyl sulfate); Fenugreek seed; | 10-16-2014 |
20140314719 | IBS Treatment - The invention relates to treatment of Irritable Bowel Syndrome using probiotic preparations containing viable, metabolically active probiotic bacteria. | 10-23-2014 |
20140328803 | Compositions and Methods - Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health. | 11-06-2014 |
20140341856 | METHOD OF CONTROLLING TOMATO PLANT VIRUSES - The method of controlling tomato plant viruses involves inoculation of an uninfected plant with a combination of a cucumber mosaic virus (CMV-KU1) associated with a naturally occurring benign viral satellite RNA with a mixture of two plant growth-promoting | 11-20-2014 |
20140348795 | NUTRITIONAL BEVERAGE POWDER AND METHOD OF MAKING SAME - A nutraceutical compound designed to promote cellular health, cleanse and replenish a body's gastro-intestinal tract and system, balance a body's natural defense system, keep the immune system high, and keep intestinal bacteria feeding on the correct enzymes is disclosed. More specifically, a nutraceutical compound that includes glutathione, carnosin, B vitamins, amino acids, probiotics, aloe vera, chlorella, spirulina, fruit powders, superfoods, and minerals is disclosed. | 11-27-2014 |
20140348796 | BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS - This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions. | 11-27-2014 |
20140356329 | PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS - The present invention provides probiotic compositions suitable for reducing the incidence and duration of human illness. In particular, the present invention provides methods and compositions suitable for preventing disease in young children. In some particularly preferred embodiments, the present invention finds use in the prevention respiratory disease in children. | 12-04-2014 |
20140363397 | METHOD FOR TREATMENT OF DISORDERS OF THE GASTROINTESTINAL SYSTEM - There are provided novel synthetic stool preparations comprising bacteria isolated from a fecal sample from a healthy donor. The synthetic stool preparations are used for treating disorders of the gastrointestinal tract, including dysbiosis, | 12-11-2014 |
20150017128 | STRAINS OF LACTIC ACID BACTERIA AND/OR BIFIDOBACTERIA INHIBITING/REDUCING THE GROWTH OF DIFFERENT BIOTYPES OF E. COLI AND DIFFERENT BIOTYPES OF CLOSTRIDIA - The present disclosure refers to strains of lactic bacteria and/or bifidobacteria having activity of inhibiting/reducing the growth of different biotypes of | 01-15-2015 |
20150037285 | METHODS FOR EFFICIENT TRANSFER OF VIABLE AND BIOACTIVE MICROBIOTA - The present invention relates to methods for transferring gastrointestinal microbiota that preserves viability and bioactivity of the microbiota, even if fastidious, anaerobic, and non-culturable organisms are present. Also provided herein are examples of how manipulating the gastrointestinal microbiota and introducing particular taxa can be used to affect host metabolic status related to weight, fat, and obesity. | 02-05-2015 |
20150044172 | PROBIOTIC COMPOSITIONS AND METHODS - The present invention relates to probiotic compositions and methods of using such compositions. In particular, the present invention provides method of using | 02-12-2015 |
20150044173 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 02-12-2015 |
20150050244 | Entomopathogenic Fungi and Uses Thereof - The present invention provides a strain of entomopathogenic | 02-19-2015 |
20150050245 | METHODS AND DELIVERY SYSTEM FOR BENEFICIAL ADDITIVE AND SUBTRACTIVE BIOLOGICAL AGENTS TO PROMOTE BALANCED MAMMALIAN GASTROINTESTINAL FLORA - This invention relates to controlled release formulations of probiotic bacteria and bacteriophages, including combined formulations of probiotic bacteria and bacteriophages. The formulations contain a hydrophilic agent, an electrolytic agent and a polysaccharide and may be in tablet form for oral delivery to the intestinal system. In one preferred aspect, the formulations of the present invention effect the simultaneous introduction or addition of probiotic bacteria and bacteriophages to cause the subtraction or removal of undesirable bacteria. | 02-19-2015 |
20150079039 | SINUSITIS DIAGNOSTICS AND TREATMENTS - Provided herein are compositions for improving sinus microbiota and treating sinusits. Further provided are methods of detecting imbalance in the sinus microbiota that can be indicative of sinusitis, and methods of determining whether an individual has or is at risk of developing sinusitis, e.g., chronic sinusitis. | 03-19-2015 |
20150079040 | PROBIOTIC BACTERIA - The invention provides probiotic bacteria and lysates thereof for use in methods of medical and cosmetic treatment. Use in the treatment of infections, including skin infections and methods involving regeneration or repair of the skin barrier are contemplated. | 03-19-2015 |
20150079041 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 03-19-2015 |
20150093360 | COMPOSITIONS AND METHODS - Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health. | 04-02-2015 |
20150104418 | BACTERIAL COMPOSITION - A bacterial composition that inhibits | 04-16-2015 |
20150104419 | FEEDLOT ADMINISTERED BACTERIAL COMPOSITION - A feedlot administered animal feed additive that promotes animal health and growth, reduces mortality and can act as an antibiotic substitute. The additive inhibits pathogen growth resulting in lower pathogen load within the animal and reduced pathogen sheading to the environment. The additive includes bacteria that inhibits | 04-16-2015 |
20150104420 | DAIRY ADMINISTERED BACTERIAL COMPOSITION - A dairy administered animal feed additive that promotes animal health and growth, reduces scours and mortality, and can act as an antibiotic substitute. The additive inhibits pathogen growth resulting in lower pathogen load within the animal and reduced pathogen sheading to the environment. The additive includes bacteria that inhibits | 04-16-2015 |
20150104421 | CALF ADMINISTERED BACTERIAL COMPOSITION - A feed additive administered to juvenile animals such as calves that promotes animal health and growth, reduces scours and mortality, and can act as an antibiotic substitute. The additive inhibits pathogen growth resulting in lower pathogen load within the animal and pathogen sheading. The additive includes bacteria that inhibits | 04-16-2015 |
20150104422 | FOS-BASED PREBIOTIC AND BACTERIAL-BASED PROBIOTIC - A composition including a pathogen inhibiting bacterial probiotic and a fructooligosaccharide (FOS) prebiotic particularly suited as a feed additive administered to juvenile animals such as calves that promotes animal health and growth, reduces scours and mortality, and can act as an antibiotic substitute. The additive inhibits pathogen growth resulting in lower pathogen load within the animal and pathogen sheading. The prebiotic-probiotic additive includes bacteria that inhibits | 04-16-2015 |
20150104423 | USE OF BLOOD GROUP STATUS III - The present invention relates to a microbial composition which is tailored based on the spectrum of microbes found more frequently from the intestine of non-secretor individuals than from the intestine of secretor individuals. The present invention further relates to a method of tailoring a microbial composition based on the spectrum of microbes found more frequently from the intestine of non-secretor individuals than from that of secretor blood group status. The present invention relates to use of the secretor status of an individual as a criterion for microbial supplementation tailored based on the differences in the spectra of microbes found between secretor and non-secretor individuals. | 04-16-2015 |
20150118190 | LACTOBACILLUS RHAMNOSUS AND BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS FOR USE IN PREVENTION OR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS - The present invention relates to a composition comprising | 04-30-2015 |
20150118191 | THERAPEUTIC BACTERIOPHAGE COMPOSITIONS - The present invention provides methods of designing panels of bacteriophages as therapeutic compositions against bacterial infections. The present invention also provides panels of bacteriophages for use in the prevention or treatment of bacterial infections. | 04-30-2015 |
20150147297 | COMPOSITIONS AND METHODS FOR REDUCING THE INCIDENCE OF EQUINE DIGESTIVE DISORDERS - The present invention encompasses compositions and methods of reducing the incidence of equine digestive disorders. A combination of either composition A (ASSURE PLUS®) and composition B (ASSURE®) or a combination of composition A (ASSURE PLUS®) and composition C (ASSURE GUARD®) may be administered to the equine. | 05-28-2015 |
20150297643 | INHIBITION OF RHO AND OR ROCK AND CELL TRANSPLANTATION - The present disclosure provides a multi-treatment combination to improve recovery after spinal cord injury or neurotrauma comprising: (a) Cell transplantation at the site of spinal cord injury and (b) Surgical delivery of BA-210. The combined treatment allows cells to be transplanted in the injury site during the acute trauma period, a time when the inflammatory response to neurotrauma adversely effects survival of transplanted cells. Early therapy delivered during critical care treatment after neurotrauma is essential for successful restorative therapy. The multi-treatment combination also provides a method to ensure that multi-potent transplanted cells do not become tumorigenic. | 10-22-2015 |
20150297647 | ENTEROCOCCUS FAECIUM EF08 STRAIN, A USE, A FEED ADDITIVE AND A FEED THEREOF | 10-22-2015 |
20150299665 | METHOD FOR REPROGRAMMING OF HUMAN DENTAL PULP CELL USING OCT4 AND SOX2 AND USE THEREOF - The present invention relates to a method for producing endothelial progenitor cells, comprising a method for producing induced pluripotent stem cells by using only Oct4 and Sox2 as a reprogramming factor of human dental pulp cells, and differentiating endothelial progenitor cells from the induced pluripotent stem cells produced by the method for producing induced pluripotent stem cells. Moreover, the present invention relates to a method for producing endothelial cells, comprising differentiating endothelial cells from endothelial progenitor cells produced by the method for producing the endothelial progenitor cells. Additionally, the present invention relates to a method for producing smooth muscle cells, comprising differentiating smooth muscle cells from endothelial progenitor cells produced by the method for producing the endothelial progenitor cells. | 10-22-2015 |
20150306154 | STRAINS AND METHODS USEFUL FOR MYCOTOXINS - The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are | 10-29-2015 |
20150306155 | PROBIOTIC RECOLONISATION THERAPY - The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic | 10-29-2015 |
20150320807 | STRAIN OF BIFIDOBACTERIUM ANIMALIS SSP. ANIMALIS - The invention relates to a novel strain of | 11-12-2015 |
20150320808 | BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS - This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure. | 11-12-2015 |
20150328267 | COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY - The invention provides a composition for use in therapy of lactose intolerance or conditions arising from lactase deficiency, wherein the composition is a non-dairy solid dosage form comprising:
| 11-19-2015 |
20150335681 | Biocomposites Having Viable Stem Cells and Platelets and Methods for Making and Using the Same - Aspects of the present disclosure include methods for preparing biocomposites having viable stem cells and platelets. Methods according to certain embodiments include combining a composition that contains viable stem cells with a composition the contains platelets in a centrifugation vessel, subjecting the centrifugation vessel to a force of centrifugation to produce two or more fractions such that each fraction includes a component having different density and collecting a fraction from the centrifuge vessel that includes the platelets and viable stem cells. Liquid biocomposites having viable stem cells and platelets and methods for administering the biocomposites to a body site of a subject are also provided. | 11-26-2015 |
20150335688 | PROBIOTIC COMBINATIONS AND USES THEREOF - The present disclosure relates generally to compositions and methods to provide probiotic supplements useful for the therapeutic and/or prophylactic treatment, amelioration and/or regulation of disease states or pathological conditions. More specifically the present disclosure relates to compositions comprising at least one probiotic microorganism, optionally in combination with one or more of orotic acid or a salt thereof, carnitine and/or coenzyme Q10, and to uses of such compositions for the treatment or prevention of fatigue, for promoting synthesis of adenosine triphosphate (ATP), for muscle repair and the treatment of muscle degeneration, muscle aches and inflammation, and/or for boosting energy levels, by improving mitochondrial function. | 11-26-2015 |
20150343004 | COMPOSITION FOR USE AS A SUPPORT THERAPY FOR TREATMENT OF TUMOURS, AIDS AND LEUKAEMIA - Described in the instant application are methods and compositions for support therapy in antitumor chemotherapeutic treatments, in acquired immunodeficiency syndrome treatments and in leukemia treatments. Said methods and compositions comprise a bacterial strain belonging to the species | 12-03-2015 |
20150352161 | USE OF HAFNIA ALVEI FOR REDUCING THE CARRIAGE OF ESCHERICHIA COLI PRODUCING SHIGA TOXINS (STEC) IN RUMINANTS - The invention relates to a method for reducing the risk of contamination of milk and meat when milking and slaughtering ruminants carrying STEC. The invention especially relates to a method for reducing the carriage of STEC by ruminants, characterised by the administration of at least one strain of | 12-10-2015 |
20150352162 | BABY FOOD COMPOSITION COMPRISING VIABLE PROPIONIC ACID-PRODUCING BACTERIA - The present invention relates to compositions, particularly baby food compositions, comprising living lactate-utilizing propionic acid-producing bacteria, as well as viable lactic-acid producing bacteria, its manufacture and use in the treatment of digestive diseases, particularly for treatment of infantile colic, intestinal discomfort, intestinalpain, visceral sensitivity, and intestinal cramp. | 12-10-2015 |
20150359894 | PROBIOTIC ORAL DOSAGE FORMS - Provided are probiotic compositions that have enhanced stability under various storage conditions. The stability of the probiotic compositions is enhanced through the addition of various agents and excipients. Examples of agents and excipients that may be used to enhance the stability of probiotic compositions include prebiotics, such as the sugar alcohols mannitol, sorbitol, and lactitol, and/or phytonutrients such as oligomeric proanthocyanidins (OPCs). The probiotic compositions may be formulated into oral dosage forms such as tablets, caplets, and capsules, or manufactured as a chewing gum or as a powder formulation that may be dissolved in a liquid such as water, milk, juice, or yogurt. | 12-17-2015 |
20150373994 | COMPOSITIONS AND METHODS FOR TREATING PESTS - Disclosed herein are pest controlling compositions comprising entomopathogenic fungi which are horizontally transmissible across pest populations and control target pests at various life stages. Further disclosed are methods of using such compositions for controlling pests, including, bed bugs and other invasive parasitic pests. | 12-31-2015 |
20150374760 | METHODS FOR TREATING PSORIASIS AND PSORIATIC ARTHRITIS - Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) and psoriasis (Ps) are encompassed herein, as are methods for identifying pathogenic dysbiosis in a subject, the presence of which is a positive indicator of risk for developing PsA or of the presence of PsA in a subject with arthritic symptoms. | 12-31-2015 |
20160000838 | Use of Faecalibacterium Prausnitzii Htf-f (DSM 26943) to Suppress Inflammation - The present invention relates to medicine, particularly immunology and gastroenterology. Specifically, it relates to probiotic bacteria and extracts thereof for therapeutic use for the treatment of inflammatory disorders such as inflammatory bowel disease. Provided is a composition comprising as active ingredient | 01-07-2016 |
20160000839 | COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE - Methods and compositions for treating inflammatory bowel disease involve the use of targeted antibiotics in combination with probiotic formulations. The probiotics mitigate many of the deleterious side effects associated with antibiotic use and permit the antibiotic to be administered at a higher dose and for a longer duration than would otherwise be possible in the absence of the probiotic. The practice of the invention may reduce or eliminate the use of immunosuppressants in the treatment and management of IBD. | 01-07-2016 |
20160022745 | BUTYROGENIC BACTERIA AS PROBIOTICS TO TREAT CLOSTRIDIUM DIFFICILE - The subject invention pertains to the use of certain bacterial strains, particularly butyrogenic bacteria, for preparing a composition to treat and/or prevent | 01-28-2016 |
20160022746 | METHODS AND GROUPS - A method, for the identification of bacterial isolates suitable for use in bacteriotherapy, the method comprising: (i) preparing a suspension of material collected from a host harbouring microbiota; (ii) addition of an activator of bacterial spores sufficient to allow growth of bacteria from spores present in the suspension; (iii) culturing the suspension; and (iv) identification of at least one bacterial species within the culture. | 01-28-2016 |
20160022747 | Antibacterial Phage, Phage Peptides and Methods of Use Thereof - The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophages F1245/05, F168/08, F170/08, F770/05, F197/08, F86/06, F87s/06 and F91a/06, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophages and/or isolated polypeptides and methods for the treatment and prevention of bacterial infection, either alone or in combination with other antibacterial therapies, e.g., antibiotics or other phage therapies. | 01-28-2016 |
20160038546 | FACTORS EXTRACTED FROM FISH EMBRYOS AND USE OF MIXTURES THEREOF IN THE CONTROL OF STEM CELL MULTIPLICATION AND DIFFERENTIATION - A cell growth and/or differentiation factor extracted from fish embryos in selected stages of stem cell differentiation, said stages being the mid-blastula-gastrula, tail bud and pharyngula stages. The invention also provides the use of growth and differentiation factors extracted from fish embryos in the control of stem cell multiplication and differentiation. | 02-11-2016 |
20160040119 | BACTERIAL SPORE COMPOSITIONS FOR INDUSTRIAL USES - In one aspect, the present invention is directed to a plant or plant part coated with a composition comprising a bacterial spore and a germinative compound. In another aspect the present invention is directed to a method of enhancing the growth of a plant or plant part comprising coating such plant or plant part with such a composition. In yet another aspect, the present invention is directed to a composition comprising a bacterial spore and a germinative compound where such components are maintained in an inactive form. The present invention also relates to use of the compositions in wastewater treatment, environmental remediation, oil recovery, aquaculture systems, and direct fed microbials. | 02-11-2016 |
20160051600 | GELATINOUS MIXTURE OF PROBIOTICS AND PREBIOTICS WITH SYNERGIC SYMBIOTIC ACTION FOR TREATING CHRONIC RENAL DISEASE - The invention relates to the fields of application of health, biotechnology and nutrition, the aim of the invention being to provide a gelatinous mixture of probiotics and prebiotics with synergic symbiotic action for the treatment of chronic renal disease, the characteristics and components thereof reducing the concentration of uremic toxins, improving the renal function of the patient with an increase in urea, creatinine, uric acid, p-cresols or indoles in the blood. The gelatinous mixture of probiotics and prebiotics with synergic symbiotic action for the treatment of chronic renal disease is easier to administrate orally as it does not require the consumption of liquids for the administration thereof, reducing liquid retention. Another advantage of the present invention is the fact that it refers to live and active bacteria. The present invention is also used a primary source of food with known prebiotic effects, an element which is not considered in other inventions; it is not in a pharmaceutical form. The probiotic bacteria are found “live and active” and in “synergic action” with the prebiotic fibres of plant origin such as “blue agave fructans (blue agave inulin)”. | 02-25-2016 |
20160058804 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 03-03-2016 |
20160067285 | LYMPHOCYTE BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY - The present invention provides a method for determining the clinical prognosis of a human subject to the administration of a pharmaceutical composition comprising of stem cells (preferably mesenchymal stem cells), stromal cells, regulatory T-cells, fibroblasts and combinations thereof. | 03-10-2016 |
20160074445 | COMPOSITIONS AND METHODS FOR REDUCING BLOOD ALCOHOL CONTENT - Disclosed are compositions and methods for reducing blood alcohol content following alcohol consumption. The inventive compositions and methods rapidly reduce blood alcohol content and alleviate symptoms of intoxication in a subject having an elevated blood alcohol content due to alcohol consumption. | 03-17-2016 |
20160101133 | ORGANOIDS COMPRISING ISOLATED RENAL CELLS AND USE THEREOF - Described herein are organoids comprising admixtures of selected bioactive primary renal cells and a bioactive cell population, e.g., an endothelial cell populations, e.g. HUVEC cells, and methods of treating a subject in need thereof with such organoids. Further, the isolated renal cells, which may include tubular and erythropoietin {EPO}-producing kidney cell populations, and/or the endothelial cell populations may be of autologous, syngeneic, allogeneic or xenogeneic origin, or any combination thereof. Further provided are methods of treating a subject in need with the organoids. | 04-14-2016 |
20160113971 | Compositions of Microbiota and Methods Related Thereto - Methods and compositions are provided for treating weight related conditions and metabolic disorders by altering microbiota in a subject. One aspect provides methods and compositions to alter microbiota in a subject by administering to the subject a composition that includes a substantially purified microbiota from phyla such as Bacteroidetes, Proteobacteria, Firmicutes and Verrucomicrobia or orders such as Bacteroidales, Verrucomicrobiales, Clostridiales and Enterobacteriales or genera such as | 04-28-2016 |
20160113974 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 04-28-2016 |
20160120917 | COMPOSITIONS AND METHODS COMPRISING BACTERIA FOR IMPROVING BEHAVIOR IN NEURODEVELOPMENTAL DISORDERS - Some embodiments include bacterial species for use in treatment of one or more autism spectrum disorder (ASD), and/or schizophrenia symptoms in a subject in need thereof. The subject in need thereof can have a gut microbiota signature characteristic of an adult. The bacterial species can include | 05-05-2016 |
20160120920 | COMPOSITIONS AND METHODS COMPRISING BACTERIA FOR IMPROVING BEHAVIOR IN NEURODEVELOPMENTAL DISORDERS - Some embodiments include bacterial species for use in treatment of one or more autism spectrum disorder (ASD), and/or schizophrenia symptoms in a subject in need thereof. The bacterial species can include | 05-05-2016 |
20160129058 | NUTRITIONAL SUPPLEMENT SYSTEM - A multi-part nutritional supplement system supplies nutrients to a user at advantageous locations in the digestive tract. One type of dosage unit is formulated to release vitamin B12 in the stomach and intestines of the upper GI tract, advantageously in an amount that is greater than or at multiple levels of the DV (Daily Value) of vitamin B12. | 05-12-2016 |
20160129059 | MICROORGANISM BIOMASS FOR PREVENTION AND REDUCTION OF THE ADVERSE EFFECTS OF MYCOTOXINS IN DIGESTIVE TRACT - The present invention relates to microorganism biomass and a feed or food composition which can be used in preventing or reducing the adverse effects of mycotoxins in animal or human digestive tract. The biomass comprises non-living microorganism biomass obtainable by cultivating microorganism strains on a cultivation medium comprising lignocellulosic material. | 05-12-2016 |
20160130558 | MATRIX AND IMPLANT FOR TISSUE ENGINEERING - A porous matrix for tissue engineering has a first biodegradable and biocompatible polymer component forming a three-dimensional primary structure with primary pores, and further includes a second biodegradable and biocompatible polymer component other than the first polymer component selected from the group of collagens, laminin, fibronectin and mixtures thereof, wherein the second polymer component forms a three-dimensional secondary structure with secondary pores, the secondary structure being contained within the interior space of at least a part of the primary pores. | 05-12-2016 |
20160136215 | COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN - The present invention relates to a homeopathic formulation comprising dilutions of | 05-19-2016 |
20160143961 | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSUS HOST DISEASE - Probiotic compositions containing non-pathogenic microbial entities, e.g., bacterial or fungal entities, are described herein. The probiotic compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the probiotic compositions to treat or prevent transplant disorders, e.g., graft-versus-host disease (GVHD), in a subject are also provided. | 05-26-2016 |
20160143962 | PROBIOTIC COMPOSITIONS CONTAINING CLOSTRIDIALES FOR INHIBITING INFLAMMATION - Pharmaceutical compositions containing microbial entities are described herein. The pharmaceutical compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the pharmaceutical compositions to treat or prevent disorders of the local or systemic microbiome in a subject are also provided. | 05-26-2016 |
20160145571 | COMPOSITIONS FOR CELLULAR RESTORATION AND METHODS OF MAKING AND USING SAME - A method comprising obtaining a donor composition from a donor subject wherein the donor composition comprises a plurality of adult stem cell types; obtaining a receiver composition from a receiver subject wherein the receiver composition comprises a plurality of adult stem cell types; and co-culturing the donor composition and receiver composition wherein co-culturing comprises contacting the receiver composition a cell-free portion of the donor composition to produce a restored composition. Pharmaceutical compositions comprising a restored composition. | 05-26-2016 |
20160151540 | Methods for Development and Use of Minimally Polarized Function Cell Micro-Aggregate Units in Tissue Applications Using LGR4, LGR5 and LGR6 Expressing Epithelial Stem Cells | 06-02-2016 |
20160158297 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS - Compositions include probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | 06-09-2016 |
20160166602 | Food Supplement Composition | 06-16-2016 |
20160192677 | METHOD OF TREATING CORAL, A CORAL FOOD COMPOSITION AND A METHOD OF MANUFACTURE | 07-07-2016 |
20160193140 | Method for Regenerating Hair Follicles Using CD36-Expressing Dermal Sheath Cells | 07-07-2016 |
20160193256 | HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 07-07-2016 |
20160193258 | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSUS HOST DISEASE | 07-07-2016 |
20160193261 | BACTERIAL COMPOSITIONS | 07-07-2016 |
20160193262 | SUPPLEMENTION OF MATERNAL DIET | 07-07-2016 |
20160193306 | MULTI-SUPPLEMENT COMPOSITIONS | 07-07-2016 |
20160199424 | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR MODULATION OF THE MICROBIOME | 07-14-2016 |
20160199531 | PACKAGED PROBIOTIC COMPOSITION AND USES THEREOF | 07-14-2016 |
20160375066 | PROBIOTIC RECOLONISATION THERAPY - The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic Clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of | 12-29-2016 |
20160376627 | METHODS, APPARATUSES, AND SYSTEMS FOR ANALYZING MICROORGANISM STRAINS FROM COMPLEX HETEROGENEOUS COMMUNITIES, PREDICTING AND IDENTIFYING FUNCTIONAL RELATIONSHIPS AND INTERACTIONS THEREOF, AND SELECTING AND SYNTHESIZING MICROBIAL ENSEMBLES BASED THEREON - Methods, apparatuses, and systems for screening, analyzing and selecting microorganisms from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and synthesizing microbial ensembles based thereon are disclosed. Methods for identifying and determining the absolute cell count of microorganism types and strains, along with identifying the network relationships between active microorganisms and environmental parameters, are also disclosed. | 12-29-2016 |
20170232048 | Adherent Dental Synbiotic Lozenge for Oral and General Health | 08-17-2017 |
20180021399 | COMPOSITION AND USE THEREOF IN MANUFACTURE OF PRODUCT FOR IMPROVING INTESTINAL FUNCTION | 01-25-2018 |
20190144923 | Microbiome Markers and Therapies for Autism Spectrum Disorders | 05-16-2019 |